Dilaudid (hydromorphone) is significantly stronger than morphine. On a milligram-for-milligram basis, hydromorphone is roughly 5 times more potent than oral morphine, meaning a much smaller dose produces the same level of pain relief. This doesn’t mean it provides “better” pain control in every situation, but it does mean the numbers on the prescription label will look very different between the two drugs.
How the Potency Compares
The standard equianalgesic conversion, used by clinicians to switch patients between opioids, breaks down like this: 25 mg of oral morphine provides roughly the same pain relief as 5 mg of oral hydromorphone. For intravenous doses, 10 mg of morphine equals about 2 mg of hydromorphone. The CDC assigns hydromorphone a morphine milligram equivalent (MME) conversion factor of 5.0, confirming that each milligram of hydromorphone carries five times the analgesic weight of a milligram of morphine.
Higher potency per milligram does not automatically mean a stronger experience for the patient. Doctors adjust the dose so that both drugs can deliver equivalent pain relief. The practical difference is volume: you need far less hydromorphone to reach the same effect, which matters when someone can’t tolerate large pill sizes or high-volume injections.
Why Hydromorphone Is More Potent
The difference comes down to how tightly each drug latches onto the brain’s primary pain-relief receptor, called the mu-opioid receptor. Opioids are ranked by their binding affinity, measured as a Ki value, where a lower number means a tighter grip. Morphine falls in the moderate range (between 1 and 100 nanomolar), while hydromorphone sits in the highest-affinity category (below 1 nanomolar), alongside drugs like oxymorphone and fentanyl. That tighter binding is the molecular reason a smaller dose of hydromorphone can match or exceed what morphine does.
Speed and Duration of Effect
Hydromorphone also acts faster. Given intravenously, it begins working within about 5 minutes and hits peak effect in 8 to 20 minutes, with pain relief lasting 1 to 2 hours. Taken by mouth, it kicks in around 30 minutes and lasts 3 to 4 hours. Morphine’s oral formulations generally have a similar onset window but can take longer to reach full effect, and its duration varies depending on whether the formulation is immediate-release or extended-release.
That faster onset is one reason hydromorphone is commonly used in emergency departments for acute pain. A meta-analysis comparing the two in over 1,000 patients found that a single intravenous dose of hydromorphone provided slightly better analgesia than morphine for acute pain in emergency settings.
Side Effects: Where They Differ
Both drugs cause the classic opioid side effects: nausea, constipation, sedation, and slowed breathing. But the profile is not identical.
- Histamine release and itching: Morphine triggers more histamine release than hydromorphone. This means morphine is more likely to cause itching, flushing, and hives. For patients with mast cell disorders or strong histamine reactions, hydromorphone is considered a safer alternative.
- Nausea and vomiting: In studies of cancer pain patients, hydromorphone consistently caused less nausea and vomiting than morphine.
- Constipation: Results here are mixed. Some cancer pain studies found less constipation with hydromorphone, while others found slightly more. Both drugs slow the gut significantly.
- Respiratory effects: In one study of patients receiving epidural doses after orthopedic surgery, hydromorphone was associated with fewer episodes of respiratory depression and less urinary retention than morphine.
When One Is Preferred Over the Other
Morphine remains the most widely used opioid worldwide and serves as the reference standard against which all other opioids are measured. It’s available in a broad range of formulations, including extended-release versions for chronic pain, and it’s well understood after decades of clinical use.
Hydromorphone tends to be favored in specific situations. Patients with kidney problems often tolerate it better because morphine produces a metabolite that builds up when the kidneys aren’t clearing it efficiently, potentially causing excessive sedation or other complications. Hydromorphone’s metabolites are generally less problematic in that scenario.
For cancer pain, a meta-analysis published in the British Journal of Anaesthesia found that hydromorphone provided slightly better analgesia than morphine across multiple studies, with fewer episodes of vomiting and drowsiness. That combination of equal or better pain control with a somewhat cleaner side effect profile makes it a common second choice when morphine causes too many problems.
What “Stronger” Actually Means for You
If you’re comparing these two drugs because you or someone you know is being switched from one to the other, the key point is this: potency and effectiveness are different things. Hydromorphone is more potent, meaning less drug is needed per dose. But when dosed correctly, both can provide the same level of pain relief. A switch from morphine to hydromorphone doesn’t necessarily mean the pain is getting worse or that treatment is escalating. It may simply mean the care team is looking for fewer side effects, faster onset, or better tolerability for a specific medical situation.
When doctors convert between the two, they typically start the new drug at 50% to 75% of the calculated equivalent dose rather than the full amount. This safety margin accounts for the fact that people metabolize opioids differently, and a dose that’s mathematically equivalent on paper can hit harder or lighter depending on the individual.